Clinical Trials in Boston

Showing 4641-4660 of 17,836 trials

RECRUITING< 1 mile

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

NCT05587439

The purpose of this research study is to learn more about the inherited risk for developing lung cancer.

Lung CancerGenetic DiseaseGenetic Predisposition+1 more

Dana-Farber Cancer Institute500 participantsStarted Jan 2023

Boston, Massachusetts, United States • Boston, Massachusetts, United States

Active Not RecruitingPhase 3< 1 mile

RNS System NAUTILUS Study

NCT05147571

To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduction of primary generalized seizures in individuals 12 years of age or older who have drug-resistant idiopathic generalized epilepsy.

EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure

NeuroPace100 participantsStarted Aug 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +20 more locations

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

RNS System NAUTILUS Study

Find Trials by Condition in Boston

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)